Luteolin
(often misspelled Leuteolin) and rutin do not directly silence or reduce the extra copy of chromosome 21 genes. They act downstream on the consequences of that overexpression—especially neuroinflammation, oxidative stress, APP/Aβ-related pathology, and impaired hippocampal neurogenesis. trisomy21research.org
Down syndrome (trisomy 21) overexpresses HSA21 genes such as APP, BACE2, interferon receptors (IFNAR1/2, IFNGR2), SOD1, DYRK1A, and others. This drives chronic interferon/JAK-STAT and NF-κB signaling, microglial activation, elevated cytokines (IL-1, IL-6, TNF-α), COX-2 activity, oxidative stress, reduced BDNF/ERK signaling, and early Alzheimer’s-like changes.
Luteolin
and rutin are used together in some targeted nutritional protocols (e.g., TNI/Nutrivene) specifically to counter these effects. trisomy21research.org
Luteolin
In the Ts65Dn mouse model of Down syndrome, four weeks of luteolin (10 mg/kg) improved Morris water maze and novel-object recognition performance. It increased hippocampal nestin, GFAP, DCX+ immature neurons, NeuN+ mature neurons, BDNF, and phosphorylated ERK1/2, consistent with restored neurogenesis via the BDNF/ERK pathway. pubmed.ncbi.nlm.nih.gov
Luteolin
also:
• Shifts microglia toward an anti-inflammatory, neuroprotective transcriptome and reduces TNF-α, IL-1, and IL-6. trisomy21research.org
• Suppresses NF-κB and p38 MAPK signaling (shown in Aβ-induced blood-brain-barrier inflammation models).
• Is the major metabolite of apigenin. Prenatal apigenin in T21 amniocytes and Ts1Cje mice downregulated pro-inflammatory genes and NF-κB/IFN signaling while upregulating pro-neurogenic genes (Nestin, Sox2, Pax6, Neurog1/2). cell.com
These actions address the inflammatory and neurogenic deficits that follow HSA21 overexpression rather than reducing the gene dosage itself.
Rutin
Rutin is a quercetin glycoside with strong antioxidant and anti-inflammatory activity. In APP-overexpressing transgenic mice (relevant because APP is triplicated in DS), dietary rutin:
• Lowered APP expression and BACE1 activity.
• Raised the GSH/GSSG ratio, reduced lipid peroxidation (MDA), and decreased IL-1β and IFN-γ. mdpi.com
• Inhibited COX-2, IL-8, and NF-κB, limited plaque-related hippocampal damage, and helped maintain glutathione. trisomy21research.org
It can also activate MAPK/ERK and BDNF expression in Aβ-toxicity models and, in some studies, enhance microglial clearance of Aβ.
Rutin is also a powerful superoxide scavenger making it incredibly important in preventing oxidative stress.
Combined effects
The two flavonoids are complementary:
•
Luteolin
more strongly modulates microglia and supports BDNF/ERK-driven neurogenesis.
• Rutin more strongly supports redox balance (GSH) and can reduce APP processing and NF-κB-driven inflammation.
Together they are intended to dampen the inflammatory cascade triggered by overexpressed APP, interferon-pathway genes, and related HSA21 products, while supporting compensatory neurotrophic signaling. They do not function as specific DYRK1A kinase inhibitors in the way EGCG has been studied; computational work on related flavones (apigenin, naringenin) shows possible binding to DYRK1A or APP, but this is not established for the luteolin + rutin pair in DS models. mdpi.com
Evidence is a mix of DS-mouse neurogenesis data (luteolin), AD/APP-overexpression models (rutin and related flavonoids), inflammation pathway studies, and clinical-protocol use. Human randomized trials of this exact combination for gene-expression or pathway correction in Down syndrome are lacking. Effects are therefore best viewed as mitigation of downstream pathology rather than correction of the primary gene-dosage imbalance.
English
Español de México
Português
Français